Tesla's Trials and Technological Triumphs

Last year was a big year for Neuralink, Elon Musk’s brain implant company, seeing as it made headlines by successfully inserting a chip into a human’s brain. Soon the world may marvel at a quadriplegic man playing chess using nothing but his mind. And while there are other companies in the field of neurotechnology, Neuralink has received outsized attention thanks to its deeply controversial founder. His ultimate ambitions are lofty—including characteristically extreme claims of products that can enable mental control of robotic limbs or substitute spoken communication all together.

But brainwave-powered chess aside, as the South Africa native becomes more famous (or infamous) for his role as President Donald Trump’s government-gutting deputy than co-founder of an embattled electric car company, Neuralink has managed to endure his notoriety. In this week’s episode, David Papadopoulos catches up with Bloomberg technology editor Sarah Frier to discuss what Neuralink has been up to, how its fundraising is going and what the company’s plans are for 2025. Also, Papadopoulos talks with Musk reporter Dana Hull and Bloomberg Businessweek senior writer Max Chafkin about Tuesday’s Tesla earnings call. Coming at a tumultuous time for the company, Musk has promised it will also be a “company update.” Chafkin and Hull break down what to expect. 

See omnystudio.com/listener for privacy information.